机构：[1]Tianjin Med Univ Canc Inst Hosp, Tianjin, Peoples R China[2]Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China[3]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China河北医科大学第四医院[4]Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China[5]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China[6]GloriousMed Clin Lab Co Ltd, Shanghai, Peoples R China[7]GloriousMed Clin Lab Co Ltd, Res Inst, Shanghai, Peoples R China
Wang Kun,Chen Xusheng,Zhang Zhenting,et al.Biomarker Exploration for neoadjuvant chemotherapy with gemcitabine combined with cisplatin in muscle-invasive bladder cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):E16556-E16556.doi:10.1200/JCO.2022.40.16_suppl.e16556.
APA：
Wang, Kun,Chen, Xusheng,Zhang, Zhenting,Hu, Hailong,Zhang, Aili...&Yao, Xin.(2022).Biomarker Exploration for neoadjuvant chemotherapy with gemcitabine combined with cisplatin in muscle-invasive bladder cancer.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Wang, Kun,et al."Biomarker Exploration for neoadjuvant chemotherapy with gemcitabine combined with cisplatin in muscle-invasive bladder cancer".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022):E16556-E16556
医学